News & Events :: Pasithea Therapeutics Corp. (KTTA)

Recent News View All News

Apr 20, 2026 7:01am EDT

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

Apr 1, 2026 7:01am EDT

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings